Bionik Laboratories Corp
OTC:BNKL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Bionik Laboratories Corp
OTC:BNKL
|
CA |
|
A
|
Antisense Therapeutics Ltd
OTC:ATHJF
|
AU |
|
Theravance Biopharma Inc
F:0TB
|
KY |
|
K
|
Kin Mining NL
ASX:KIN
|
AU |
|
Gravity (India) Ltd
BSE:532015
|
IN |
|
Norseman Silver Inc
OTC:FTZFF
|
CA |
|
Atled Corp
TSE:3969
|
JP |
Shareholder Yield
Current shareholder yield for BNKL is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
BNKL Price
Bionik Laboratories Corp
| Average Annual Return | -61.66% |
| Standard Deviation of Annual Returns | 35.52% |
| Max Drawdown | -100% |
| Market Capitalization | 1.2k USD |
| Shares Outstanding | 12 480 000 |
| Percentage of Shares Shorted |
N/A
|
BNKL Return Decomposition
Main factors of price return
Stock Splits
BNKL's latest stock split occurred on Oct 30, 2018
The company executed a 1-for-150 stock split, meaning that for every 150 shares held, investors received 1 new share.
Before the split, BNKL traded at 0.0497 per share. Afterward, the share price was about 12.5.
The adjusted shares began trading on Oct 30, 2018. This was stock split number 3 in BNKL's history, following the previous one in Feb 13, 2015.
